Factors Affecting the Price of Alpelisib

Alpelisib is an oral phosphatidylinositol-3-kinase alpha (PI3Kα) inhibitor, belonging to the class of kinase inhibitory drugs. By specifically inhibiting the activity of PI3Kα, alpelisib can block the abnormal activation of the PI3K/Akt signaling pathway, thereby reducing excessive cell proliferation and abnormal tissue growth caused by PIK3CA gene mutations.

Alpelisib(PIQRAY)
PIQRAY is indicated in combination with fulvestrant for the treatment of HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on...
RELATED ARTICLES
Are the side effects of Alpelisib serious?

Alpelisib is an inhibitor that targets the PI3K pathway, specifically the PI3Kα isoform. Mutations in the...

Monday, July 7th, 2025, 11:28
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved